financetom
Business
financetom
/
Business
/
ED files chargesheet against Mehul Choksi, 13 others
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
ED files chargesheet against Mehul Choksi, 13 others
Jun 28, 2018 4:56 AM

The Enforcement Directorate (ED) on Thursday filed chargesheet against Mehul Choksi and 13 others including five companies, named in the PNB fraud case.

Diamantaire Nirav Modi, his uncle Mehul Choksi and others are being probed by various agencies after the fraud came to light in February following a complaint from PNB, accusing that they allegedly cheated the nationalised bank to the tune of over Rs 13,000 crore.

The bank had issued letter of undertakings (LoU) of Rs 3,011.39 crore and foreign letters of credit (FLC) of Rs 3,086.24 crore to three companies of Choksi — Gitanjali Gems Ltd, Gili India and Nakshatra brands.

Choksi used to allegedly divert these funds to related companies in USA, UK, UAE, Thailand, China, Japan, Italy and Belgium.

On Wednesday, Nirav Modi and Choksi approached the Central Bureau of Investigation's (CBI) special court in Mumbai for cancellation of non-bailable warrant against them.

Also read: PNB fraud: Mehul Choksi fears threat to life due to mob lynching trend, says report

Two non-bailable warrants were issued against Choksi in the month of April and May.

Choksi on Thursday said that he could not travel to India because of possible threat to his life.

In his application, Choksi also said that he always responded to the summons received from the CBI or any other investigating agency.

First Published:Jun 28, 2018 1:56 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved